Electrospun Biodegradable Scaffold for Bone Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone repair methods, such as autografts and allografts, face issues like tissue scarcity, donor site morbidity, and limited success due to the lack of viable biological components for osteoinduction, and there is a need for effective delivery systems for growth factors to enhance bone regeneration.
Innovation Solution
Development of electrospun composite scaffolds comprising a polyester, a hydrophilic polymer, and a growth factor like PDGF-BB, optionally with a bioceramic, to support osteogenic differentiation and bone repair by sustained release of growth factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional autografts and allografts are used for bone repair, then bone void filling is achieved, but tissue scarcity and donor site morbidity occur
Solution Approach 1:
The patent employs electrospun scaffolds made from biodegradable polymers that temporarily fulfill the bone void filling function and then degrade as native bone regenerates. These disposable-like scaffolds eliminate the need for permanent implantation and avoid donor site morbidity associated with traditional grafts.
Solution Approach 2:
The invention uses composite materials combining electrospun polymer fibers with bone morphogenetic proteins and other bioactive components. This composite approach provides both the mechanical scaffold structure and the biological signals needed for bone regeneration, replacing the need for traditional autografts or allografts.
2Strength
If processed acellular allografts are used to fill bone voids, then mechanical compatibility is achieved, but osteoinduction capability is lost
Solution Approach 1:
The patent merges the mechanical scaffold function with the biological osteoinduction function by incorporating bone morphogenetic proteins and living cells directly into the electrospun scaffold structure. This combination ensures both mechanical support and active bone regeneration capability simultaneously.
Solution Approach 2:
The electrospun scaffold acts as an intermediary carrier that delivers bone morphogenetic proteins and cells to the bone defect site. This intermediary structure provides both mechanical support and facilitates biological osteoinduction through controlled release of growth factors.
3Area of stationary object
If growth factors are systemically delivered during fracture healing, then broad distribution is achieved, but effectiveness at target site is reduced
Solution Approach 1:
The patent implements local quality by concentrating bone morphogenetic proteins and other growth factors specifically at the bone defect site through the electrospun scaffold. This localized delivery ensures high effectiveness at the target site without the need for systemic administration, avoiding dilution and off-target effects.
Solution Approach 2:
The electrospun scaffold serves as a local intermediary reservoir that holds and gradually releases growth factors at the fracture site. This intermediary system provides sustained local concentration of biologics exactly where needed, overcoming the limitations of systemic delivery.
4Area of stationary object
If electrospun scaffolds are used for growth factor delivery, then high surface area-volume ratio is achieved, but preservation of growth factor bioactivity becomes challenging
Solution Approach 1:
The patent employs parameter changes by carefully controlling the electrospinning process parameters (voltage, flow rate, distance) and polymer composition to create scaffold conditions that preserve growth factor bioactivity. The specific fiber diameter, porosity, and surface chemistry are optimized to maintain protein stability while providing high surface area.
Solution Approach 2:
The invention uses composite materials combining biocompatible polymers with protective agents and bone morphogenetic proteins. The composite structure provides a protective microenvironment that preserves growth factor bioactivity while maintaining the high surface area-volume ratio characteristic of electrospun scaffolds.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scaffolds enhance the osteogenic differentiation of mesenchymal stem cells, improve bone growth, and support bone repair by maintaining bioactivity and controlled release of growth factors, leading to increased bone formation and healing.
Implementation Method 1
Electrospinning has been recently utilized in the field of tissue engineering as a scaffold fabrication technique to prepare non-woven scaffolds with fiber diameters on the order of nanometers to microns
Implementation Method 2
The high surface area-volume ratio of the fibers generated in the electrospinning process, makes it an ideal vehicle for various drug delivery applications
Data Source
AI summary
This invention relates a structure and system for growth factor incorporation which can improve the osteogenic differentiation of hMSCs, for potential bone regeneration and bone growth applications or used alone for bone repair or growth applications. The system comprises a biodegradable polyester, a hydrophilic polymer, a growth factor and optionally a bioceramic.